Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 5OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 202Gynecologic 6Thoracic 5Head & Neck 4Genitourinary 4Breast 4Dermatologic 3Other neoplasm 2Sarcoma 1Other solid neoplasm 1Other 1

Conditions

Melanoma 1654Skin Neoplasms 355Lymphoma, T-Cell, Cutaneous 322Carcinoma, Basal Cell 240Mycosis Fungoides 227Sezary Syndrome 209Breast Neoplasms 196Leukemia, Lymphocytic, Chronic, B-Cell 193Lymphoma, Non-Hodgkin 192Lymphoma, Follicular 187Precursor Cell Lymphoblastic Leukemia-Lymphoma 183Lymphoma, Large B-Cell, Diffuse 183Lymphoma, B-Cell, Marginal Zone 182Lymphoma, Mantle-Cell 181Hodgkin Disease 175Lymphoma 173Burkitt Lymphoma 173Uveal Melanoma 170Lymphoma, Large-Cell, Immunoblastic 168Multiple Myeloma 159Keratosis, Actinic 146Neoplasms 142Leukemia, Myeloid, Acute 134Neoplasm Metastasis 125Lymphoma, Large-Cell, Anaplastic 125Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 123Lung Neoplasms 120Immunoblastic Lymphadenopathy 115Leukemia, Myeloid, Accelerated Phase 113Leukemia, Myeloid, Chronic-Phase 112

Interventions

pembrolizumab 2Nivolumab 2tislelizumab 1spartalizumab 1Rosiglitazone 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma Of Esophagus × Dermatologic × Clear all
NCT04114136 2026-04-24

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

University of Pittsburgh

Phase 2 Recruiting
72 enrolled
DermatologicGastrointestinalHead & Neck

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hepatocellular, Melanoma

NCT07223424 2026-04-16

PSI-Immune

University of Pittsburgh

Phase 2 Recruiting
880 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT04802876 2025-03-21

ACROPOLI

SOLTI Breast Cancer Research Group

Phase 2 Active not recruiting
184 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Uveal Melanoma, Anus Neoplasms, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Neoplasms, Unknown Primary, Sarcoma, Thyroid Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡